Новости за 10.06.2016

A bill to help Puerto Rico manage its debt crisis cleared the House of Representatives on Thursday, but faces some resistance as it heads to the Senate.

Lenovo Group Ltd. unveiled the first smartphone based on Google’s Project Tango, a technology designed to measure and map surrounding objects and spaces.

Lenovo Group Ltd. unveiled the first smartphone based on Google’s Project Tango, a technology designed to measure and map surrounding objects and spaces.

Model S suspension issues may have led to recall avoidance measures.

Twitter Inc. has notified millions of users that their accounts are at risk of being taken over after a file containing close to 33 million purported usernames and passwords for the social-blogging service was made public Wednesday.

Twitter Inc. has notified millions of users that their accounts are at risk of being taken over after a file containing close to 33 million purported usernames and passwords for the social-blogging service was made public Wednesday.

Twitter Inc. has notified millions of users that their accounts are at risk of being taken over after a file containing close to 33 million purported usernames and passwords for the social-blogging service was made public Wednesday.

Twitter Inc. has notified millions of users that their accounts are at risk of being taken over after a file containing close to 33 million purported usernames and passwords for the social-blogging service was made public Wednesday.

Has Wall Street’s biggest permabear lost his teeth? Marc Faber doesn’t sound so downbeat on equities right now.

Has Wall Street’s biggest permabear lost his teeth? Marc Faber doesn’t sound so downbeat on equities right now.

Investors who want to take advantage of big demographic shifts and significant consumer trends have been handed some new investment products, including obesity- and fitness-themed ETFs

Down payment assistance programs can slash closing costs, but few buyers know about them.

Sophiris Bio Inc. shares surged in the extended session Thursday after the tiny biotech's prostate cancer treatment showed promising results in a mid-stage clinical study. Sophiris shares rallied 74% to $2.04 on heavy volume after hours. The company said its treatment topsalysin showed an ability to destroy tumor cells in nine out of the 18 prostate cancer patients treated in a clinical study. "These promising early results open up the possibility of treating early prostate cancer by the simple... Читать дальше...